A/H5N1 inactivated, split-virion influenza virus
Sponsors
Sanofi Pasteur, a Sanofi Company
Conditions
InfluenzaOrthomyxoviridae Infections
Phase 2
Safety and Immunogenicity of an Intramuscular Pandemic Influenza Vaccine in Adults and the Elderly
CompletedNCT00415129
Start: 2006-06-30End: 2009-03-31Updated: 2014-01-14
Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults
CompletedNCT00545701
Start: 2007-10-31End: 2008-09-30Updated: 2014-01-14